Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Enrollment completed in phase IIa study of brostallicin in soft tissue carcinoma

Aug. 12, 2008

Oncolytics completes dose escalation in REO 010 clinical trial of Reolysin and docetaxel

Aug. 12, 2008

Recent patents disclose new anticancer compounds

Aug. 12, 2008

Lixte's compounds for brain tumors demonstrate activity in pancreatic cancer models

Aug. 11, 2008

Geron initiates enrollment in phase I/II clinical trial of GRN-163L in breast cancer

Aug. 11, 2008

Sound's chemoprotectant drug cleared for phase II hearing loss trial

Aug. 11, 2008

Novel agents potentially useful for the treatment of cancer reported in recent patents

Aug. 8, 2008

Sonus signs exclusive in-licensing agreement with Bayer Healthcare for caspase activators

Aug. 8, 2008

FDA grants orphan drug designation to SuperGen's MP-470 in glioblastoma multiforme

Aug. 8, 2008

Bayer acquires preclinical oncology program from Nycomed

Aug. 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...